Abound Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4
Closed -$1.34K 1312
2024
Q3
$1.34K Hold
4
﹤0.01% 749
2024
Q2
$1.65K Hold
4
﹤0.01% 659
2024
Q1
$1.62K Hold
4
﹤0.01% 707
2023
Q4
$1.23K Buy
+4
New +$1.08K ﹤0.01% 735

Other funds holding MEDP

Abound Wealth Management's MEDP Position: Q4 2024 in Review

Abound Wealth Management sold out of Medpace (MEDP) in Q4 2024, closing a stake of 4 shares — an estimated $1.34K sold.

Abound Wealth Management first reported a position in MEDP in Q4 2023 and held it in 4 quarters. The position peaked at $1.65K in Q2 2024. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Abound Wealth Management reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Abound Wealth Management sold 4 Medpace shares in Q4 2024, an estimated $1.34K.
  • Abound Wealth Management first reported a position in Medpace in Q4 2023 and held it in 4 quarters.
  • Abound Wealth Management's Medpace position peaked at $1.65K in Q2 2024.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Abound Wealth Management's 13F filing for Q4 2024, filed 13 Jan 2025.